FDA Hits Immunomedics for Data Integrity Breach, Other Violations

Drug Industry Daily
A A
The FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.

To View This Article:

Login

Subscribe To Drug Industry Daily